ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy

Andrea M. Russo, Raymond F. Stainback, Steven R Bailey, Andrew E. Epstein, Paul A. Heidenreich, Mariell Jessup, Suraj Kapa, Mark S. Kremers, Bruce D. Lindsay, Lynne Warner Stevenson, Michael B. Alexander, Ulrika Birgersdotter-Green, Alan S. Brown, Richard A. Grimm, Paul J. Hauptman, Sharon A. Hunt, Rachel Lampert, Joann Lindenfeld, David J. Malenka, Kartik ManiJoseph E. Marine, Edward T. Martin, Richard L. Page, Michael W. Rich, Paul D. Varosy, Mary Norine Walsh, Michael J. Wolk, John U. Doherty, Pamela S. Douglas, Robert C. Hendel, Christopher M. Kramer, James K. Min, Manesh R. Patel, Leslee Shaw, Joseph M. Allen

Research output: Contribution to journalArticle

215 Citations (Scopus)

Abstract

Original languageEnglish
Pages (from-to)1318-1368
Number of pages51
JournalJournal of the American College of Cardiology
Volume61
Issue number12
DOIs
StatePublished - Mar 26 2013

Fingerprint

Cardiac Resynchronization Therapy
Implantable Defibrillators
Equipment and Supplies
Comorbidity
Clinical Trials
Primary Prevention
Secondary Prevention
Life Expectancy
Practice Guidelines
Cognition
Decision Making
Delivery of Health Care
Physicians
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy. / Russo, Andrea M.; Stainback, Raymond F.; Bailey, Steven R; Epstein, Andrew E.; Heidenreich, Paul A.; Jessup, Mariell; Kapa, Suraj; Kremers, Mark S.; Lindsay, Bruce D.; Stevenson, Lynne Warner; Alexander, Michael B.; Birgersdotter-Green, Ulrika; Brown, Alan S.; Grimm, Richard A.; Hauptman, Paul J.; Hunt, Sharon A.; Lampert, Rachel; Lindenfeld, Joann; Malenka, David J.; Mani, Kartik; Marine, Joseph E.; Martin, Edward T.; Page, Richard L.; Rich, Michael W.; Varosy, Paul D.; Walsh, Mary Norine; Wolk, Michael J.; Doherty, John U.; Douglas, Pamela S.; Hendel, Robert C.; Kramer, Christopher M.; Min, James K.; Patel, Manesh R.; Shaw, Leslee; Allen, Joseph M.

In: Journal of the American College of Cardiology, Vol. 61, No. 12, 26.03.2013, p. 1318-1368.

Research output: Contribution to journalArticle

Russo, AM, Stainback, RF, Bailey, SR, Epstein, AE, Heidenreich, PA, Jessup, M, Kapa, S, Kremers, MS, Lindsay, BD, Stevenson, LW, Alexander, MB, Birgersdotter-Green, U, Brown, AS, Grimm, RA, Hauptman, PJ, Hunt, SA, Lampert, R, Lindenfeld, J, Malenka, DJ, Mani, K, Marine, JE, Martin, ET, Page, RL, Rich, MW, Varosy, PD, Walsh, MN, Wolk, MJ, Doherty, JU, Douglas, PS, Hendel, RC, Kramer, CM, Min, JK, Patel, MR, Shaw, L & Allen, JM 2013, 'ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy', Journal of the American College of Cardiology, vol. 61, no. 12, pp. 1318-1368. https://doi.org/10.1016/j.jacc.2012.12.017
Russo, Andrea M. ; Stainback, Raymond F. ; Bailey, Steven R ; Epstein, Andrew E. ; Heidenreich, Paul A. ; Jessup, Mariell ; Kapa, Suraj ; Kremers, Mark S. ; Lindsay, Bruce D. ; Stevenson, Lynne Warner ; Alexander, Michael B. ; Birgersdotter-Green, Ulrika ; Brown, Alan S. ; Grimm, Richard A. ; Hauptman, Paul J. ; Hunt, Sharon A. ; Lampert, Rachel ; Lindenfeld, Joann ; Malenka, David J. ; Mani, Kartik ; Marine, Joseph E. ; Martin, Edward T. ; Page, Richard L. ; Rich, Michael W. ; Varosy, Paul D. ; Walsh, Mary Norine ; Wolk, Michael J. ; Doherty, John U. ; Douglas, Pamela S. ; Hendel, Robert C. ; Kramer, Christopher M. ; Min, James K. ; Patel, Manesh R. ; Shaw, Leslee ; Allen, Joseph M. / ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy. In: Journal of the American College of Cardiology. 2013 ; Vol. 61, No. 12. pp. 1318-1368.
@article{0156be20c20a4d04af0704cc1d311aec,
title = "ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy",
abstract = "The American College of Cardiology Foundation in collaboration with the Heart Rhythm Society and key specialty and subspecialty societies conducted a review of common clinical scenarios where implantable cardioverterdefibrillators (ICDs) and cardiac resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered in this document address secondary prevention, primary prevention, comorbidities, generator replacement at elective replacement indicator, dual-chamber ICD, and CRT. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and Results: of studies examining device implantation. The 369 indications in this document were developed by a multidisciplinary writing group and scored by a separate independent technical panel on a scale of 1 to 9 to designate care that is Appropriate (median 7 to 9), May Be Appropriate (median 4 to 6), and Rarely Appropriate (median 1 to 3). The final ratings reflect the median score of the 17 technical panel members: 45{\%} of the indications were rated as Appropriate, 33{\%} were rated May Be Appropriate and 22{\%} were rated Rarely Appropriate. In general, Appropriate designations were assigned to scenarios for which clinical trial evidence and/or clinical experience was available that supported device implantation. By contrast, scenarios for which clinical trial evidence was limited or device implantation seemed reasonable for extenuating reasons were categorized as May Be Appropriate. Scenarios for which there were data showing harm, or no data were available, and medical judgment deemed device therapy ill-advised were categorized as Rarely Appropriate. For example, comorbidities including life expectancy and cognitive function impacted appropriateness ratings. The Appropriate Use Criteria for ICD/CRT have the potential to enhance physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of clinical scenarios rated as May Be Appropriate facilitates the identification of areas that would benefit from future research.",
keywords = "ACCF appropriate use criteria, CRT, Electrophysiology, Heart failure, ICD, Implantable defibrillator, Sudden death",
author = "Russo, {Andrea M.} and Stainback, {Raymond F.} and Bailey, {Steven R} and Epstein, {Andrew E.} and Heidenreich, {Paul A.} and Mariell Jessup and Suraj Kapa and Kremers, {Mark S.} and Lindsay, {Bruce D.} and Stevenson, {Lynne Warner} and Alexander, {Michael B.} and Ulrika Birgersdotter-Green and Brown, {Alan S.} and Grimm, {Richard A.} and Hauptman, {Paul J.} and Hunt, {Sharon A.} and Rachel Lampert and Joann Lindenfeld and Malenka, {David J.} and Kartik Mani and Marine, {Joseph E.} and Martin, {Edward T.} and Page, {Richard L.} and Rich, {Michael W.} and Varosy, {Paul D.} and Walsh, {Mary Norine} and Wolk, {Michael J.} and Doherty, {John U.} and Douglas, {Pamela S.} and Hendel, {Robert C.} and Kramer, {Christopher M.} and Min, {James K.} and Patel, {Manesh R.} and Leslee Shaw and Allen, {Joseph M.}",
year = "2013",
month = "3",
day = "26",
doi = "10.1016/j.jacc.2012.12.017",
language = "English",
volume = "61",
pages = "1318--1368",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy

AU - Russo, Andrea M.

AU - Stainback, Raymond F.

AU - Bailey, Steven R

AU - Epstein, Andrew E.

AU - Heidenreich, Paul A.

AU - Jessup, Mariell

AU - Kapa, Suraj

AU - Kremers, Mark S.

AU - Lindsay, Bruce D.

AU - Stevenson, Lynne Warner

AU - Alexander, Michael B.

AU - Birgersdotter-Green, Ulrika

AU - Brown, Alan S.

AU - Grimm, Richard A.

AU - Hauptman, Paul J.

AU - Hunt, Sharon A.

AU - Lampert, Rachel

AU - Lindenfeld, Joann

AU - Malenka, David J.

AU - Mani, Kartik

AU - Marine, Joseph E.

AU - Martin, Edward T.

AU - Page, Richard L.

AU - Rich, Michael W.

AU - Varosy, Paul D.

AU - Walsh, Mary Norine

AU - Wolk, Michael J.

AU - Doherty, John U.

AU - Douglas, Pamela S.

AU - Hendel, Robert C.

AU - Kramer, Christopher M.

AU - Min, James K.

AU - Patel, Manesh R.

AU - Shaw, Leslee

AU - Allen, Joseph M.

PY - 2013/3/26

Y1 - 2013/3/26

N2 - The American College of Cardiology Foundation in collaboration with the Heart Rhythm Society and key specialty and subspecialty societies conducted a review of common clinical scenarios where implantable cardioverterdefibrillators (ICDs) and cardiac resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered in this document address secondary prevention, primary prevention, comorbidities, generator replacement at elective replacement indicator, dual-chamber ICD, and CRT. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and Results: of studies examining device implantation. The 369 indications in this document were developed by a multidisciplinary writing group and scored by a separate independent technical panel on a scale of 1 to 9 to designate care that is Appropriate (median 7 to 9), May Be Appropriate (median 4 to 6), and Rarely Appropriate (median 1 to 3). The final ratings reflect the median score of the 17 technical panel members: 45% of the indications were rated as Appropriate, 33% were rated May Be Appropriate and 22% were rated Rarely Appropriate. In general, Appropriate designations were assigned to scenarios for which clinical trial evidence and/or clinical experience was available that supported device implantation. By contrast, scenarios for which clinical trial evidence was limited or device implantation seemed reasonable for extenuating reasons were categorized as May Be Appropriate. Scenarios for which there were data showing harm, or no data were available, and medical judgment deemed device therapy ill-advised were categorized as Rarely Appropriate. For example, comorbidities including life expectancy and cognitive function impacted appropriateness ratings. The Appropriate Use Criteria for ICD/CRT have the potential to enhance physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of clinical scenarios rated as May Be Appropriate facilitates the identification of areas that would benefit from future research.

AB - The American College of Cardiology Foundation in collaboration with the Heart Rhythm Society and key specialty and subspecialty societies conducted a review of common clinical scenarios where implantable cardioverterdefibrillators (ICDs) and cardiac resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered in this document address secondary prevention, primary prevention, comorbidities, generator replacement at elective replacement indicator, dual-chamber ICD, and CRT. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and Results: of studies examining device implantation. The 369 indications in this document were developed by a multidisciplinary writing group and scored by a separate independent technical panel on a scale of 1 to 9 to designate care that is Appropriate (median 7 to 9), May Be Appropriate (median 4 to 6), and Rarely Appropriate (median 1 to 3). The final ratings reflect the median score of the 17 technical panel members: 45% of the indications were rated as Appropriate, 33% were rated May Be Appropriate and 22% were rated Rarely Appropriate. In general, Appropriate designations were assigned to scenarios for which clinical trial evidence and/or clinical experience was available that supported device implantation. By contrast, scenarios for which clinical trial evidence was limited or device implantation seemed reasonable for extenuating reasons were categorized as May Be Appropriate. Scenarios for which there were data showing harm, or no data were available, and medical judgment deemed device therapy ill-advised were categorized as Rarely Appropriate. For example, comorbidities including life expectancy and cognitive function impacted appropriateness ratings. The Appropriate Use Criteria for ICD/CRT have the potential to enhance physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of clinical scenarios rated as May Be Appropriate facilitates the identification of areas that would benefit from future research.

KW - ACCF appropriate use criteria

KW - CRT

KW - Electrophysiology

KW - Heart failure

KW - ICD

KW - Implantable defibrillator

KW - Sudden death

UR - http://www.scopus.com/inward/record.url?scp=84877284718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877284718&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2012.12.017

DO - 10.1016/j.jacc.2012.12.017

M3 - Article

C2 - 23453819

AN - SCOPUS:84877284718

VL - 61

SP - 1318

EP - 1368

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 12

ER -